PRESS RELEASE published on 08/04/2023 at 16:30, 1 year 3 months ago Iute Group EUR 2021/2026 bondholders with great consent to amend terms and conditions – Bondholders’ Meeting secures greater financial flexibility for growth
PRESS RELEASE published on 07/13/2023 at 11:30, 1 year 4 months ago Iute initiates process to amend terms and conditions of EUR 2021/2026 bonds – Invitation to Bondholders’ Meeting on 3 August 2023
PRESS RELEASE published on 07/12/2023 at 14:00, 1 year 4 months ago Iute announces settlement and listing of EUR 10 million tap on EUR 2021/2026 bonds Total volume of bonds outstanding EUR 125 million
PRESS RELEASE published on 07/05/2023 at 15:00, 1 year 4 months ago Iute places EUR 10 million tap on EUR 2021/2026 bonds in connection with exchange offer for EUR 2019/2023 bonds – Total volume of bonds outstanding EUR 125 million
PRESS RELEASE published on 05/30/2023 at 16:20, 1 year 5 months ago Iute after continued interest from investors with renewed exchange offer for EUR bond 2019/2023 – Tap of EUR Bond 2021/2026 by up to EUR 10 million
PRESS RELEASE published on 05/29/2023 at 07:30, 1 year 5 months ago Iute Group reports unaudited results for 3M/2023 – Quality over quantity for financial year 2023
PRESS RELEASE published on 05/11/2023 at 09:00, 1 year 6 months ago Iute Group reports unaudited 3M 2023 results on 29 May 2023 – Invitation to earnings webcast/call on 30 May 2023
PRESS RELEASE published on 04/06/2023 at 17:00, 1 year 7 months ago Iute announces settlement and listing of EUR 40 million tap on EUR 2021/2026 bonds - Total volume of bonds outstanding EUR 115 million
PRESS RELEASE published on 03/31/2023 at 18:00, 1 year 7 months ago Iute places EUR 40 million tap on EUR 2021/2026 bonds – Strong appetite from existing investors boosted by new subscriptions
PRESS RELEASE published on 03/30/2023 at 07:30, 1 year 7 months ago Iute with strong Appetite from existing investors for EUR 2021/2026 bonds exchange offer – Public Offer for EUR 2021/2026 Bonds continues until 31 March 2023
Published on 11/21/2024 at 13:30, 29 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 29 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 59 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 59 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 59 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 24 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 44 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 1 minute ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 39 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
